Transcription factor GATA3 and the human HDR syndrome - PubMed
Review
Transcription factor GATA3 and the human HDR syndrome
H Van Esch et al. Cell Mol Life Sci. 2001 Aug.
Abstract
Recently, a member of the GATA-binding family of transcription factors was shown to be involved in the human hypoparathyroidism, sensorineural deafness and renal anomalies (HDR) syndrome. Deletion-mapping studies and subsequent mutation analysis revealed that haploinsufficiency for GATA3 is the underlying mechanism of the HDR syndrome. Here we discuss the clinical characteristics of the HDR syndrome and present an overview of the role of GATA3 and related GATA-binding transcription factors during vertebrate embryonic development and their involvement in human disease.
Similar articles
-
GATA3 haplo-insufficiency causes human HDR syndrome.
Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K. Van Esch H, et al. Nature. 2000 Jul 27;406(6794):419-22. doi: 10.1038/35019088. Nature. 2000. PMID: 10935639
-
Identification of a novel insertion mutation in GATA3 with HDR syndrome.
Mino Y, Kuwahara T, Mannami T, Shioji K, Ono K, Iwai N. Mino Y, et al. Clin Exp Nephrol. 2005 Mar;9(1):58-61. doi: 10.1007/s10157-004-0327-6. Clin Exp Nephrol. 2005. PMID: 15830275
-
GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.
Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T. Muroya K, et al. J Med Genet. 2001 Jun;38(6):374-80. doi: 10.1136/jmg.38.6.374. J Med Genet. 2001. PMID: 11389161 Free PMC article.
-
GATA3 and kidney development: why case reports are still important.
Van Esch H, Bilous RW. Van Esch H, et al. Nephrol Dial Transplant. 2001 Nov;16(11):2130-2. doi: 10.1093/ndt/16.11.2130. Nephrol Dial Transplant. 2001. PMID: 11682654 Review. No abstract available.
-
Hasegawa T, Hasegawa Y, Aso T, Koto S, Nagai T, Tsuchiya Y, Kim KC, Ohashi H, Wakui K, Fukushima Y. Hasegawa T, et al. Am J Med Genet. 1997 Dec 31;73(4):416-8. doi: 10.1002/(sici)1096-8628(19971231)73:4<416::aid-ajmg9>3.0.co;2-l. Am J Med Genet. 1997. PMID: 9415468 Review.
Cited by
-
Huang B, Li S, Chai Y, Fan Y, Li X, Liu Y, Fu Y, Song X, Cui J. Huang B, et al. Mol Genet Metab Rep. 2024 Jan 30;38:101063. doi: 10.1016/j.ymgmr.2024.101063. eCollection 2024 Mar. Mol Genet Metab Rep. 2024. PMID: 38469092 Free PMC article.
-
Yeşiltepe Mutlu G, Kırmızıbekmez H, Nakamura A, Fukami M, Hatun Ş. Yeşiltepe Mutlu G, et al. J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):344-8. doi: 10.4274/jcrpe.2249. J Clin Res Pediatr Endocrinol. 2015. PMID: 26777049 Free PMC article.
-
Peng H, Ke XX, Hu R, Yang L, Cui H, Wei Y. Peng H, et al. Mol Med Rep. 2015 Feb;11(2):881-6. doi: 10.3892/mmr.2014.2809. Epub 2014 Oct 29. Mol Med Rep. 2015. PMID: 25351211 Free PMC article.
-
GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.
Zhu ZY, Zhou QL, Ni SN, Gu W. Zhu ZY, et al. World J Pediatr. 2014 Aug;10(3):278-80. doi: 10.1007/s12519-014-0505-x. Epub 2014 Aug 15. World J Pediatr. 2014. PMID: 25124981
-
Chen X, Zou C. Chen X, et al. Mol Genet Genomic Med. 2024 Apr;12(4):e2433. doi: 10.1002/mgg3.2433. Mol Genet Genomic Med. 2024. PMID: 38591167 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources